Latest Insider Transactions at Silverback Therapeutics, Inc. (SBTX)
This section provides a real-time view of insider transactions for Silverback Therapeutics, Inc. (SBTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silverback Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silverback Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2020
|
Thilo Schroeder Director |
BUY
Open market or private purchase
|
Indirect |
238,096
+50.0%
|
$5,000,016
$21.0 P/Share
|
|
Dec 08
2020
|
Jonathan Piazza Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
11,904
+50.0%
|
$249,984
$21.0 P/Share
|
|
Dec 08
2020
|
Russ Hawkinson Sr. Vice President of Finance |
BUY
Open market or private purchase
|
Direct |
238
+50.0%
|
$4,998
$21.0 P/Share
|
|
Dec 08
2020
|
Vickie L Capps Director |
BUY
Open market or private purchase
|
Direct |
9,523
+13.39%
|
$199,983
$21.0 P/Share
|
|
Dec 08
2020
|
Presidio Management Group Xii, L.L.C. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
47,619
+50.0%
|
$999,999
$21.0 P/Share
|
|
Dec 08
2020
|
Presidio Management Group Xii, L.L.C. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,174,179
+31.13%
|
-
|
|
Dec 08
2020
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,190,477
+40.97%
|
$25,000,017
$21.0 P/Share
|
|
Dec 08
2020
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
7,011,765
+28.91%
|
-
|